From Fred Ezeh, Abuja
Global Fund, a worldwide movement to defeat HIV, Tuberculosis (TB) and malaria, has confirmed that $16. 946 billion was committed to the fight against HIV, TB and Malaria in Nigeria between 2002 and 2022.
Global Fund in its Result Report for 2022 posted on its twitter account, yesterday, indicated that $1.1billion investment was made on HIV response in Nigeria, $15.4b investment was made on malaria response, while $446 million was spent on TB response in the period under review.
On HIV/AIDS, the Global Fund report indicated that 1.8 million people were put on antiretroviral therapy for HIV, 6.2 million
HIV tests were taken, 34,000 mothers living with HIV received medicine to keep them alive and prevent transmission to their babies, while 1.7 million people were reached with HIV prevention services.
On TB, the report revealed that 208,000 people were treated for TB; 7,400 HIV positive TB patients were included on antiretroviral, 18,000 people exposed to TB received preventive therapy, while there was no data on people put on treatment for extensively drug-resistant TB.
On Malaria, the report indicated that 16.3 million mosquito nets were distributed across communities, 2.4 million pregnant women received preventive treatment for malaria, while 26.1 million suspected cases were tested for malaria, and there was no data on structures covered by indoor residual spraying.
The report confirmed that a child dies of malaria every minute. Nevertheless, a great progress has been made in malaria control with a reduction in overall cases and deaths, but that momentum has stalled in recent years.
It stressed that COVID-19 exacerbated the challenge, while resistances to insecticides and treatments show signs of spreading, adding that Global Fund partnership response has been to innovate by investing in tools such as dual active ingredient nets and to continue what has worked such as funding the mass distribution of long-lasting insecticidal nets, seasonal chemoprevention, rapid diagnostic tests and quality-assured treatment; supporting regional manufacturing; and strengthening national efforts to make testing as widely available as possible.
Global Fund added that the implementation of U.S President’s Emergency Plan for AIDS Relief (PEPFAR) and WHO’s “treat all” guidance and the UNAIDS “95-95-95” strategy have significantly increased the number of people diagnosed with HIV and started on antiretroviral therapy.